Accumulation of aberrant DNA methylation during colorectal cancer development.
about
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.The gastrointestinal microbiota and colorectal cancer.Gut microbiome and colorectal adenomas.Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.The role of epigenetics in colorectal cancer.Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells.MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.Case-control study of candidate gene methylation and adenomatous polyp formation.Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer.DNA methylation analysis of secreted frizzled-related protein 2 gene for the early detection of colorectal cancer in fecal DNA.Epigenetic and genetic dispositions of ovarian carcinomasColorectal cancer: epigenetic alterations and their clinical implications.Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer.Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.
P2860
Q34654615-F24F3EB5-5C0E-4E26-AB0D-1BFE1B2A5882Q35138535-20C3DC38-209C-40FC-9957-46CF8A2A7266Q35172970-049507B1-8F09-40CD-BF03-493A1DDEBBE0Q36359503-CD1279A0-0A4F-4CC8-B82D-C0C65B77A67AQ37267725-3670E436-0459-4F54-B90C-3C3B357B5497Q37295663-EA1CFD0B-8826-4706-B93F-B1A127339C23Q37729102-3C5B8EB9-B808-4FC6-A2E8-A72E4AC76832Q38215665-EBAD40DA-0159-470F-82B2-0420FE66A621Q38731088-35C79C00-2A36-4931-9A1E-EC5BA70E2199Q38762957-E3EF58AA-AC1E-4698-AD1B-C20AA7609CCCQ39258008-85D9FE1F-1C31-4B63-9C16-4C3F46EA790DQ40975165-BD59F0FD-87A1-49DB-816A-EE0EBB4B9022Q41304718-A6B69A28-1B61-4D33-A7BB-38825793BC87Q42112898-B56C0F3B-22A3-4079-99DF-B17567215FBFQ46112381-E5252598-6612-40F7-B458-90FFAF88DE1CQ47152584-EE200852-F6BF-4FE8-B3BB-F7AE30821F3BQ47645638-D07EF11D-9DCD-4CDC-B98F-B23003734880Q49372166-4A21A223-C43C-478E-A35F-E181200BDE64
P2860
Accumulation of aberrant DNA methylation during colorectal cancer development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Accumulation of aberrant DNA methylation during colorectal cancer development.
@en
Accumulation of aberrant DNA methylation during colorectal cancer development.
@nl
type
label
Accumulation of aberrant DNA methylation during colorectal cancer development.
@en
Accumulation of aberrant DNA methylation during colorectal cancer development.
@nl
prefLabel
Accumulation of aberrant DNA methylation during colorectal cancer development.
@en
Accumulation of aberrant DNA methylation during colorectal cancer development.
@nl
P2093
P2860
P356
P1476
Accumulation of aberrant DNA methylation during colorectal cancer development.
@en
P2093
Atsushi Kaneda
Atsushi Nakajima
Eiji Sakai
P2860
P304
P356
10.3748/WJG.V20.I4.978
P407
P577
2014-01-01T00:00:00Z